
A majority of women with an early form of a common breast cancer may be able to skip chemotherapy, depending on the results of a comprehensive gene test. The new study of nearly 7,000 women found that use of the already available Oncogene DX gene test could pinpoint those women who needed chemotherapy, and those… read on >